Pfizer Inc (PFE)
Number of days of payables
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Number of days of payables | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ —
= —
The data provided for Pfizer Inc's number of days of payables is not available for analysis across the specified periods from March 31, 2020, to December 31, 2024. The absence of specific figures for the number of days of payables in this timeframe hinders the ability to assess the company's efficiency in managing its accounts payable turnover. Payables turnover ratio and days payable outstanding are key metrics that can provide insights into how long it takes the company to pay off its suppliers.
Without the actual values, it is challenging to determine if Pfizer is effectively managing its payables by optimizing payment terms with suppliers. A lower number of days of payables could indicate efficient cash flow management, while higher days of payables might signal possible liquidity issues or strained supplier relationships. Tracking this metric over time can reveal trends and patterns in Pfizer's payment practices, contributing to a more comprehensive financial analysis.
Peer comparison
Dec 31, 2024